ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Lamellar Transplant With Lyophilized Corneas

This study has been completed.

Sponsors and Collaborators: Federal University of São Paulo
University of Sao Paulo
Sorocaba Eye Bank
Information provided by: Federal University of São Paulo
ClinicalTrials.gov Identifier: NCT00409955
  Purpose

- The goals of this study are to develop a lyophilization method for anterior lamellar transplants in Brasil and to make a comparative analysis among patients transplanted with lyophilized and optisol corneas


Condition Intervention Phase
Keratoconus
Procedure: Lamellar transplant with lyophilized corneas
Phase II

ChemIDplus related topics:   Oprelvekin   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   Randomized Clinical Trial for Lamellar Transplants Using Lyophilized and Optisol Corneas

Further study details as provided by Federal University of São Paulo:

Primary Outcome Measures:
  • Topography
  • Orbscan
  • Pachmetry
  • Ultrasound Biomicroscopy
  • Confocal Microscopy
  • Masked Examiner to evaluate transparency and quality of the transplant

Estimated Enrollment:   20
Study Start Date:   December 2005
Estimated Study Completion Date:   December 2006

Detailed Description:
  • After the development of a techinique to lyophilize corneas, we randomly assingned 20 patients with keratoconus and visual acuity of < 20/60, who signed the consent term and divided them into 2 groups. One group was transplanted with lyophilized corneas and the other group with optisol corneas.
  • Patients are being followed for 6 months with visual acuity, refraction, topography, orbscan, pachmetry, ultrasound biomicroscopy and confocal microscopy.
  • Results are going to be statistically analysed by SPSS program.
  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Keratoconus patient
  • BCVA < 20/60
  • No systemic diseases
  • Who signed the inform consent

Exclusion Criteria:

  • BCVA > 20/60
  • Presence of deep opacities
  • Systemic diseases
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00409955

Locations
Brazil, SP
Federal University of Sao Paulo    
      São Paulo, SP, Brazil, 04023-062

Sponsors and Collaborators
Federal University of São Paulo
University of Sao Paulo
Sorocaba Eye Bank

Investigators
Principal Investigator:     Roberta JM Farias, MD     Federal University of Sao Paulo    
  More Information

Study ID Numbers:   CEP 1536/05
First Received:   December 11, 2006
Last Updated:   December 11, 2006
ClinicalTrials.gov Identifier:   NCT00409955
Health Authority:   Brazil: National Health Surveillance Agency

Keywords provided by Federal University of São Paulo:
Lamellar transplant  
Lyophilization  
Corneas storage  
Keratoconus patients
Best corrected visual acuity < 20/60
Signed the consent inform

Study placed in the following topic categories:
Corneal Diseases
Oprelvekin
Eye Diseases
Keratoconus

ClinicalTrials.gov processed this record on August 20, 2008




Links to all studies - primarily for crawlers